News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
260 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17556)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (304)
2 (302)
3 (234)
4 (222)
5 (108)
6 (3)
7 (15)
8 (212)
9 (260)
10 (221)
11 (237)
12 (101)
13 (4)
14 (12)
15 (202)
16 (227)
17 (235)
18 (206)
19 (47)
20 (2)
21 (1)
22 (157)
23 (253)
24 (233)
25 (241)
26 (126)
27 (6)
28 (11)
29 (245)
30 (295)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK
Pomerantz LLP is investigating claims on behalf of investors of Merrimack Pharmaceuticals, Inc..
April 9, 2019
·
1 min read
BioCapital
Aziyo Announces Publication of RECON Study of Pericardial Reconstruction Using ProxiCor
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day Hospital Readmission Rates
April 9, 2019
·
3 min read
BioMidwest
Senior Helpers® of Rochester to Host Dementia and Caregiving Seminars
Nationally Renowned Dementia Expert Teepa Snow Partners with Leading In-Home Senior Care Provider to Deliver Valuable Caregiving Insights
April 9, 2019
·
3 min read
Business
St. Jude Children’s Research Hospital celebrates Tau Kappa Epsilon’s achievement of $2.6 million fundraising commitment
Fraternity members nationwide band together to achieve fundraising commitment for children fighting cancer and other life-threatening diseases
April 9, 2019
·
3 min read
Business
Bravado Health launches new patient discharge product
Bravado Health unveils the first core product of its new patient engagement platform with the launch of Ayva Discharge.
April 9, 2019
·
2 min read
Pharm Country
Daiichi Sankyo’s EZH1/2 Dual Inhibitor Valemetostat (DS-3201) Receives SAKIGAKE Designation for Treatment of Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from Japan MHLW
SAKIGAKE Designation will provide development support and accelerated review of valemetostat, an investigational and potential first-in-class EZH1/2 dual inhibitor, for relapsed/refractory peripheral T-cell lymphoma (PTCL)
April 9, 2019
·
7 min read
FDA
FDA Clears VITROS® XT Chemistry Product Slides from Ortho Clinical Diagnostics
Groundbreaking XT MicroSlides Deliver Accurate Results from 2 Simultaneous Miniaturized Tests, Simplifying Workflow and Improving Turnaround Time in the Lab
April 9, 2019
·
3 min read
Business
Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing
Revance Therapeutics, Inc. announced a pivotal addition to its leadership team with the appointment of Taryn Conway as Vice President, Marketing, effective April 8, 2019.
April 9, 2019
·
3 min read
Business
Harris Corporation to Provide New Fully Digital Signals Under $243 Million GPS III Follow-On Contract
Harris Corporation has received a $243 million contract from Lockheed Martin to provide fully digital navigation signals for the first two GPS III Follow-On (GPS IIIF) satellites – to deliver stronger signals, with greater operational flexibility.
April 9, 2019
·
3 min read
Business
The Government of Armenia Signs Strategic Partnership with WHISE-Embleema to Modernize Digital Healthcare Through Blockchain
The Republic of Armenia Ministry of Health embraces national digital health agenda, partnering with WHISE-Embleema to digitize healthcare data in order to promote science research
April 9, 2019
·
7 min read
Previous
8 of 26
Next